Immunotherapy Stocks List

Recent Signals

Date Stock Signal Type
2019-12-12 BCTXF Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-12-12 BCTXF 1,2,3 Retracement Bearish Bearish Swing Setup
2019-12-12 BCTXF 50 DMA Resistance Bearish
2019-12-12 BCTXF Crossed Above 20 DMA Bullish
2019-12-12 GLAXF 180 Bullish Setup Bullish Swing Setup
2019-12-12 GLAXF Narrow Range Bar Range Contraction
2019-12-12 GNBT Boomer Sell Setup Bearish Swing Setup
2019-12-12 GNBT Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-12-12 GNBT 1,2,3 Retracement Bearish Bearish Swing Setup
2019-12-12 GNBT Narrow Range Bar Range Contraction
2019-12-12 GNBT NR7 Range Contraction
2019-12-12 HGEN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-12-12 HGEN Volume Surge Other
2019-12-12 HGEN Narrow Range Bar Range Contraction
2019-12-12 HGEN Pocket Pivot Bullish Swing Setup
2019-12-12 IMMG Narrow Range Bar Range Contraction
2019-12-12 IMMG Jack-in-the-Box Bearish Bearish Swing Setup
2019-12-12 IMMG Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-12-12 IMMG Expansion Breakdown Bearish Swing Setup
2019-12-12 IMMG Stochastic Buy Signal Bullish
2019-12-12 IMUC Crossed Above 20 DMA Bullish
2019-12-12 IMUC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-12-12 IMUC MACD Bullish Signal Line Cross Bullish
2019-12-12 IMUC Bollinger Band Squeeze Range Contraction
2019-12-12 IMUC Crossed Above 50 DMA Bullish
2019-12-12 MDNAF Doji - Bearish? Reversal
2019-12-12 MDNAF Pocket Pivot Bullish Swing Setup
2019-12-12 MDNAF Calm After Storm Range Contraction
2019-12-12 MDNAF Stochastic Reached Overbought Strength
2019-12-12 NWBO Bollinger Band Squeeze Range Contraction
2019-12-12 NWBO Crossed Above 20 DMA Bullish
2019-12-12 OBMP NR7 Range Contraction
2019-12-12 OBMP Narrow Range Bar Range Contraction
2019-12-12 OBMP NR7-2 Range Contraction
2019-12-12 PVCTW Stochastic Buy Signal Bullish
2019-12-12 PVCTW Hammer Candlestick Bullish
2019-12-12 PVCTW Pocket Pivot Bullish Swing Setup

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapy